- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Senzime publishes annual and sustainability report for 2023 | 106 | ACCESSWIRE | UPPSALA, SE / ACCESSWIRE / April 24, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ) announces today that the company's annual and sustainability report for 2023 is published and available... ► Artikel lesen | |
| Mi | Senzime Wins Another Major US Veterans Affairs Contract; Expands Reach of TetraGraph System | 150 | ACCESSWIRE | UPPSALA, SE / ACCESSWIRE / April 24, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in perioperative precision-based patient monitoring solutions, announced today that it has been... ► Artikel lesen | |
| 17.04. | Notice of Annual General Meeting in Senzime AB | 119 | ACCESSWIRE | UPPSALA, SWEDEN / ACCESSWIRE / April 17, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the "Company") are hereby convened to an annual general... ► Artikel lesen | |
| 10.04. | From Kids to Robots: Senzime Secures Multiple Top-Rated US Hospital Deals | 250 | ACCESSWIRE | UPPSALA, SWEDEN / ACCESSWIRE / April 10, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF), an industry leader in perioperative precision-based patient monitoring solutions, today announced additional new contracts... ► Artikel lesen | |
| 07.03. | Senzime Wins its Largest US Deal to Date from Leading Houston Based University Hospital System | 178 | ACCESSWIRE | UPPSALA, SWEDEN / ACCESSWIRE / March 7, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in precision-based patient monitoring solutions, today announces its largest hospital win to... ► Artikel lesen | |
| 15.02. | Senzime: Year-end Report January - December 2023 | 264 | ACCESSWIRE | UPPSALA, SWEDEN / ACCESSWIRE / February 15, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Press release: Uppsala, February 15, 2024. Senzime AB (publ):s Year-end report for January - December 2023 is now available... ► Artikel lesen | |
| 09.02. | Invitation to Senzime's Fourth Quarter 2023 Report Presentation | 233 | ACCESSWIRE | UPPSALA, SWEDEN / ACCESSWIRE / February 9, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime invites investors, analysts, and media to a webcast presentation of the fourth quarter report for 2023 on February... ► Artikel lesen | |
| 07.02. | Senzime Licensee Fukuda Denshi Launches Integrated TetraGraph Module in Japanese Market | 318 | ACCESSWIRE | UPPSALA, SE / ACCESSWIRE / February 7, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in algorithm-based patient monitoring solutions, today announced that Fukuda Denshi, its licensee... ► Artikel lesen | |
| 17.01. | Senzime Expands its US Commercial Operations | 247 | ACCESSWIRE | UPPSALA, SE / ACCESSWIRE / January 17, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in algorithm-based patient monitoring solutions, today announced a significant expansion of... ► Artikel lesen | |
| 21.12.23 | Senzime Secures Initial TetraGraph Order from Major New York Metropolitan Region University Hospital Group | 184 | ACCESSWIRE | UPPSALA, SWEDEN / ACCESSWIRE / December 21, 2023 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in algorithm-based patient monitoring solutions, today announces another major US hospital... ► Artikel lesen | |
| 30.11.23 | New Number of Shares and Votes in Senzime AB | 282 | ACCESSWIRE | UPPSALA, SWEDEN / ACCESSWIRE / November 30, 2023 / Senzime (STO:SEZI) The number of shares and votes in Senzime AB (publ) ("Senzime") has during the month of November increased due to the directed share... ► Artikel lesen | |
| 30.11.23 | Senzime Secures Multiple University Hospital Orders in Germany | 299 | ACCESSWIRE | UPPSALA, SE / ACCESSWIRE / November 30, 2023 / Senzime (STO:SEZI) Senzime, an industry leader in algorithm-based patient monitoring solutions, today announced that it has secured multiple new orders... ► Artikel lesen | |
| 28.11.23 | Bulletin from Extraordinary General Meeting in Senzime AB | 282 | ACCESSWIRE | UPPSALA, SE / ACCESSWIRE / November 28, 2023 / Senzime (STO:SEZI) The extraordinary general meeting in Senzime AB (publ), corp. reg. no 556565-5734 was held on 28 November 2023, whereby the shareholders... ► Artikel lesen | |
| 03.11.23 | Notice of Extraordinary General Meeting in Senzime AB | 398 | ACCESSWIRE | UPPSALA, SWEDEN / ACCESSWIRE / November 3, 2023 / Senzime (STO:SEZI) The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the "Company") are hereby convened to an extraordinary general meeting... ► Artikel lesen | |
| 27.10.23 | OTC Markets Group Welcomes Senzime AB to OTCQX | 253 | GlobeNewswire (Europe) | NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced Senzime AB (Nasdaq Stockholm:... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS | 52,28 | 0,00 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
| PROGYNY | 32,500 | 0,00 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
| RXSIGHT | 51,89 | 0,00 % | RxSight, Inc. - 8-K, Current Report | ||
| FRESENIUS | 27,030 | -0,55 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Fresenius vor Zahlen für das erste Quartal auf "Buy" mit einem Kursziel von 43 Euro belassen. Die gute Wachstumsdynamik im... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 17,990 | 0,00 % | Where Privia Health Gr Stands With Analysts | ||
| SIEMENS HEALTHINEERS | 52,32 | +0,04 % | Dividendenbekanntmachungen (19.04.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABG SUNDAL COLLIER HOLDING ASA NO0003021909 0,5 NOK 0,0425 EUR ALM BRAND A/S DK0015250344 0,55 DKK 0,0737 EUR APA CORPORATION US03743Q1085 0... ► Artikel lesen | |
| MIMEDX | 6,245 | 0,00 % | Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers | ||
| MOBILE-HEALTH NETWORK SOLUTIONS | 23,780 | 0,00 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
| IMAC HOLDINGS | 5,100 | 0,00 % | (BACK) - Analyzing IMAC Holdings' Short Interest | ||
| ATRICURE | 22,610 | 0,00 % | AtriCure upgraded at Oppenheimer on valuation | ||
| ADAPTHEALTH | 9,580 | 0,00 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 10,410 | 0,00 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Announces Recent Acquisitions That Continue to Drive Growth and Value | LOUISVILLE, Ky., March 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or "BrightSpring Health Services") (NASDAQ: BTSG), a leading provider of home and community-based... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 100,40 | +1,41 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,980 | +0,50 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für FMC vor Quartalszahlen auf "Underweight" mit einem Kursziel von 35,40 Euro belassen. Nach einem Gespräch mit der Investor-Relations-Abteilung... ► Artikel lesen | |
| EUROPEAN WAX CENTER | 11,510 | 0,00 % | European Wax Center, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results | Fiscal Year 2023 versus 2022 Net new centers increased 10.6% to 1,044 total centers in 45 statesSystem-wide sales of $955.0 million increased 6.3%Total revenue of $221.0 million increased 6.6%Same-store... ► Artikel lesen |
Das Unternehmen SENZIME AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -0,31 % bei einem Aktienkurs von 0,482 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
